Edition:
United Kingdom

Revenio Group Oyj (REG1V.HE)

REG1V.HE on Helsinki Stock Exchange

36.00EUR
12:14pm GMT
Change (% chg)

€-0.30 (-0.83%)
Prev Close
€36.30
Open
€36.30
Day's High
€36.30
Day's Low
€35.95
Volume
5,879
Avg. Vol
5,340
52-wk High
€41.41
52-wk Low
€29.23

Latest Key Developments (Source: Significant Developments)

Revenio Acquires Minority Interest In Oscare Medical
Monday, 11 Dec 2017 

Dec 11 (Reuters) - Revenio Group Oyj ::REG-REVENIO GROUP CORPORATION: REVENIO ACQUIRES MINORITY INTEREST IN OSCARE MEDICAL OY.‍SIGNED AN AGREEMENT TO PURCHASE MINORITY INTEREST IN OSCARE MEDICAL OY, A STAKE OF 46.5% IN COMPANY​.‍FOLLOWING TRANSACTION, REVENIO GROUP CORPORATION WILL OWN 100% OF OSCARE MEDICAL OY​.‍REVENIO WILL MAKE IMPAIRMENT-RELATED ENTRIES IN FINANCIAL STATEMENTS FOR 2017​.- ‍ARRANGEMENT AND IMPAIRMENTS WILL HAVE ONE-OFF EFFECT OF AROUND EUR 1.4 MILLION ON OPERATING PROFIT FOR 2017​.‍ARRANGEMENT WILL HAVE NO EFFECT ON REVENIO'S FINANCIAL GUIDANCE FOR CURRENT YEAR.​.  Full Article

Revenio Group Q3 operating proft up at EUR 2.5 mln
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - REVENIO GROUP OYJ ::Q3 NET SALES EUR ‍6.4​ MILLION VERSUS EUR 5.8 MILLION YEAR AGO.Q3 OPERATING PROFIT EUR ‍2.5​ MILLION VERSUS EUR 1.9 MILLION YEAR AGO.‍SAYS 2017 NET SALES GROWTH IS EXPECTED TO REMAIN STRONG PROFITABILITY​.  Full Article

Revenio Q2 operating profit up at EUR 1.7 million
Monday, 8 Aug 2016 

Revenio Group Oyj : Q2 net sales 5.8 million euros ($6.4 million) versus 4.9 million euros year ago . Q2 operating profit 1.7 million euros versus 1.5 million euros year ago .Net sales growth is expected to remain strong.  Full Article

Revenio appoints Timo Hildén new CEO as of Jan 1, 2017
Monday, 16 May 2016 

Revenio Group Oyj : New CEO for Revenio and expansion in management team . Has appointed Timo Hildén (born 1959) as new group CEO as of Jan. 1, 2017 . CEO Olli-Pekka Salovaara (born 1960) will leave his position after a transition period on Jan. 1, 2017 .Salovaara will continue in position of executive chairman of board of Icare USA Inc.'s.  Full Article

Revenio Group Oyj: Icare ic100 gets sales permit for US markets
Wednesday, 20 Apr 2016 

Revenio Group Oyj:Icare ic100 has received sales permit for the US markets.DA sales permit regards Icare ic100 tonometer.  Full Article

Revenio Group Oyj says FDA did not grant sales permit for Icare HOME in U.S.
Thursday, 17 Mar 2016 

Revenio Group Oyj:Says FDA did not grant sales permit for Icare HOME in the U.S.Will publish further inform about impact of negative decision as soon as possible.Says the company's unit, Icare Finland Oy, submitted in September a sales permit application for its Icare HOME tonometer for monitoring eye pressure at home.  Full Article

Revenio Group to purchase it's own shares
Thursday, 25 Feb 2016 

Revenio Group Oyj:Says to purchase it's own shares ‍.Maximum amount of 7,000 shares are to be bought on grounds of authorization given by annual general meeting on March 19, 2015.‍Shares will be purchased through public trading on Nasdaq Helsinki at market price prevailing at time of purchase​ ‍.Purchase of company's own shares will begin on Feb. 29, 2016 at earliest.Purchase of the Company's own shares will continue until the abovementioned share amount is purchased or until March 14, 2016 at the latest​​.  Full Article

Revenio Group Oyj proposes a dividend for FY 2015, provides outlook for FY 2016
Monday, 15 Feb 2016 

Revenio Group Oyj:FY ‍2016 net sales growth is expected to remain strong​.FY 2016 profitability is expected to remain at a healthy level despite growth investments​.‍Board will propose to annual general meeting of March 15, 2016 a dividend of 0.70 euros (0.45 euros last year) for FY 2015.  Full Article

BRIEF-Revenio Acquires Minority Interest In Oscare Medical

* REG-REVENIO GROUP CORPORATION: REVENIO ACQUIRES MINORITY INTEREST IN OSCARE MEDICAL OY